Magnetic resonance spectroscopy metabolite profiles predict survival in paediatric brain tumours

Martin Wilson, Carole L Cummins, Lesley Macpherson, Yu Sun, Kal Natarajan, Richard G Grundy, Theodoros N Arvanitis, Risto A Kauppinen, Andrew C Peet

Research output: Contribution to journalArticle (Academic Journal)peer-review

50 Citations (Scopus)


Brain tumours cause the highest mortality and morbidity rate of all childhood tumour groups and new methods are required to improve clinical management. (1)H magnetic resonance spectroscopy (MRS) allows non-invasive concentration measurements of small molecules present in tumour tissue, providing clinically useful imaging biomarkers. The primary aim of this study was to investigate whether MRS detectable molecules can predict the survival of paediatric brain tumour patients. PATIENTS AND METHODS: Short echo time (30ms) single voxel (1)H MRS was performed on children attending Birmingham Children's Hospital with a suspected brain tumour and 115 patients were included in the survival analysis. Patients were followed-up for a median period of 35months and Cox-Regression was used to establish the prognostic value of individual MRS detectable molecules. A multivariate model of survival was also investigated to improve prognostic power. RESULTS: Lipids and scyllo-inositol predicted poor survival whilst glutamine and N-acetyl aspartate predicted improved survival (p
Original languageEnglish
Pages (from-to)457-464
JournalEuropean Journal of Cancer
Issue number2
Early online date1 Oct 2012
Publication statusPublished - Jan 2013

Structured keywords

  • Brain and Behaviour


Dive into the research topics of 'Magnetic resonance spectroscopy metabolite profiles predict survival in paediatric brain tumours'. Together they form a unique fingerprint.

Cite this